Mortality rates higher for TAVR-treated patients with low ejection fraction

24.07.20141620
Patients who underwent transcatheter aortic valve replacement for severe aortic stenosis had higher 30-day and 1-year mortality rates if their ejection fraction was low when compared with those in the normal range.

Catheter-directed thrombolysis did not benefit, may harm patients with DVT

23.07.20141390
Researchers compared in-hospital outcomes of catheter-directed thrombolysis (CDT) plus anticoagulation with outcomes of anticoagulation alone in an observational study of 90,618 patients with proximal or caval DVT.

Is There a Link Between Alcohol Use and Risk of AFib?

21.07.20141554
Based on multiple epidemiologic studies, a relationship between alcohol intake and atrial fibrillation (AFib) has been identified, with the lowering of the former potentially being an effective means of preventing the latter.

Efficacy and Safety of Nebivolol and Valsartan as Fixed-Dose Combination in Hypertension: A Randomised, Multicentre Study

18.07.20141894
What is the efficacy and safety of a new fixed-dose combination of nebivolol and valsartan compared with monotherapy components and placebo in patients with stage 1 or 2 hypertension?

Lipid lowering in patients with treatment-resistant hypertension: an analysis from the Treating to New Targets (TNT) trial

17.07.20141444
Patients with resistant hypertension are at high risk for adverse cardiovascular events. Efforts have been focused on lowering the surrogate endpoint of blood pressure (BP) with scant focus on reduction of hard cardiovascular endpoints.

Atrial fibrillation practice patterns among cardiac electrophysiologists and cardiologists

16.07.20141275
Treatment paradigms for atrial fibrillation (AF) are highly variable. This study explores the management practices for AF between general cardiologists and electrophysiologists in an academic institution.

Beta-Blocker Therapy and Cardiac Events Among Patients With Newly Diagnosed Coronary Heart Disease

15.07.20141720
The effectiveness of beta-blockers for preventing cardiac events has been questioned for patients who have coronary heart disease (CHD) without a prior myocardial infarction (MI).
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.